Advertisement
Screener

ARIAD PHARMACEUTICALS INC Depreciation and Amortization Expense

ARIAD PHARMACEUTICALS INC Depreciation and Amortization Expense

ARIAD PHARMACEUTICALS INC reported Depreciation and Amortization Expense of $6.64 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-09.

Discontinued › Expense Statement › Operating Expenses

us-gaap:DepreciationAndAmortization · last filed 2012-08-09

  • ARIAD PHARMACEUTICALS INC depreciation, depletion and amortization, nonproduction for the quarter ending 2012-06-30 was $5.63M, a 390.41% increase year-over-year.
  • ARIAD PHARMACEUTICALS INC depreciation, depletion and amortization, nonproduction for the quarter ending 2012-03-31 was $1.01M, a 7.29% increase year-over-year.
  • ARIAD PHARMACEUTICALS INC depreciation, depletion and amortization, nonproduction for the quarter ending 2011-12-31 was -$793.00K.
  • ARIAD PHARMACEUTICALS INC depreciation, depletion and amortization, nonproduction for the quarter ending 2011-09-30 was $1.50M, a 66.11% increase year-over-year.
  • ARIAD PHARMACEUTICALS INC depreciation, depletion and amortization, nonproduction for fiscal 2011 was $2.80M, a 6.67% decline from fiscal 2010.
  • ARIAD PHARMACEUTICALS INC depreciation, depletion and amortization, nonproduction for fiscal 2010 was $3.00M, a 6.25% decline from fiscal 2009.
  • ARIAD PHARMACEUTICALS INC depreciation, depletion and amortization, nonproduction for fiscal 2009 was $3.20M.
Period endDepreciation, Depletion and Amortization, Nonproduction 3 monthDepreciation, Depletion and Amortization, Nonproduction 6 monthDepreciation, Depletion and Amortization, Nonproduction 9 monthDepreciation, Depletion and Amortization, Nonproduction 12 monthDepreciation, Depletion and Amortization, Nonproduction 12 month as first filed
2012-06-30$5.63M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$6.64M
10-Q · filed 2012-08-09
$5.85M
derived: sum of 3 quarters · filed 2012-08-09
$7.35M
derived: sum of 4 quarters · filed 2012-08-09
2012-03-31$1.01M
10-Q · filed 2012-05-09
$222.00K
derived: sum of 2 quarters · filed 2012-05-09
$1.72M
derived: sum of 3 quarters · filed 2012-05-09
$2.87M
derived: sum of 4 quarters · filed 2012-08-09
2011-12-31-$793.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-30
$707.00K
derived: sum of 2 quarters · filed 2012-03-30
$1.85M
derived: sum of 3 quarters · filed 2012-08-09
$2.80M
10-K/A · filed 2012-03-30
$4.61M
10-K · filed 2012-02-29
2011-09-30$1.50M
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07
$2.65M
derived: sum of 2 quarters · filed 2012-08-09
$3.59M
10-Q · filed 2011-11-07
$2.73M
derived: sum of 4 quarters · filed 2012-08-09
2011-06-30$1.15M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-09
$2.09M
10-Q · filed 2012-08-09
$1.23M
derived: sum of 3 quarters · filed 2012-08-09
$2.13M
derived: sum of 4 quarters · filed 2012-08-09
2011-03-31$946.00K
10-Q · filed 2012-05-09
$81.00K
derived: sum of 2 quarters · filed 2012-05-09
$984.00K
derived: sum of 3 quarters · filed 2012-05-09
2010-12-31-$865.00K
derived: 10-K/A 12 month − 10-Q 9 month · filed 2012-03-30
$38.00K
derived: sum of 2 quarters · filed 2012-03-30
$3.00M
10-K/A · filed 2012-03-30
$6.15M
10-K · filed 2012-02-29
2010-09-30$903.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07
$3.87M
10-Q · filed 2011-11-07
2010-06-30$2.96M
10-Q · filed 2011-08-09
2009-12-31$3.20M
10-K/A · filed 2012-03-30
$4.22M
10-K · filed 2012-02-29